Icahn School of Medicine at Mount Sinai-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2023

  1. Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis

    International Journal of Infectious Diseases, Vol. 131, pp. 173-179

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

  2. Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV

    AIDS, Vol. 29, Núm. 5, pp. 571-581

  3. Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: A randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents

    HIV Clinical Trials, Vol. 16, Núm. 2, pp. 72-80

2014

  1. Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study

    BMC Nephrology, Vol. 15, Núm. 1

2013

  1. Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV a randomized trial

    Annals of Internal Medicine, Vol. 159, Núm. 2, pp. 86-96

2007

  1. Care of patients coinfected with HIV and hepatitis C virus: 2007 Updated recommendations from the HCV-HIV International Panel

    AIDS, Vol. 21, Núm. 9, pp. 1073-1089

2005

  1. Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: Results of a randomized clinical study

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 10, pp. 3997-4008